ACIU - AC Immune SA

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. Estimate-0.210.08-0.63-0.36
Low estimate-0.24-0.24-0.97-0.6
High estimate-0.190.41-0.28-0.12
Year ago EPS-0.23-0.17-0.95-0.63
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. Estimate2.76M27.62M30.38M56.75M
Low estimateN/AN/AN/A32.04M
High estimate5.52M55.24M60.76M81.46M
Year ago salesN/A4.08M4.38M30.38M
Sales growth (year/est)N/A577.70%593.70%86.80%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.24-0.27-0.27-0.25
Actual EPS-0.23-0.17-0.26-0.23
Difference0.010.10.010.02
Surprise %4.20%37.00%3.70%8.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.210.08-0.63-0.36
7 days ago-0.210.09-0.62-0.36
30 days ago-0.220.08-0.65-0.37
60 days ago-0.220.08-0.65-0.36
90 days ago-0.21-0.21-0.86-0.64
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACIUIndustrySector(s)S&P 500
Current qtr.8.70%N/AN/AN/A
Next qtr.147.10%N/AN/AN/A
Current year33.70%N/AN/AN/A
Next year42.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A